nitrates has been researched along with tezosentan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ford, CA; Tabrizchi, R | 1 |
| Cotter, G; Dittrich, H; Felker, GM; Metra, M; Milo-Cotter, O; Teerlink, JR; Voors, AA; Weatherley, B | 1 |
1 review(s) available for nitrates and tezosentan
| Article | Year |
|---|---|
Vasodilators in the treatment of acute heart failure: what we know, what we don't.
Topics: Acute Disease; Atrial Natriuretic Factor; Benzoates; Elapid Venoms; Endothelin-1; Heart Failure; Humans; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nitrates; Peptide Fragments; Prognosis; Pyridines; Receptors, Endothelin; Relaxin; Tetrazoles; Vasoconstriction; Vasodilator Agents | 2009 |
1 other study(ies) available for nitrates and tezosentan
| Article | Year |
|---|---|
Haemodynamic effects of endothelin receptor antagonist, tezosentan, in tumour necrosis factor-alpha treated anaesthetized rats.
Topics: Animals; Dose-Response Relationship, Drug; Hemodynamics; Infusions, Intravenous; Lung; Male; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Pyridines; Rats; Rats, Sprague-Dawley; Tetrazoles; Time Factors; Tumor Necrosis Factor-alpha; Vasodilator Agents | 2003 |